Skip to main content
. 2021 Feb 11;9:630353. doi: 10.3389/fcell.2021.630353

FIGURE 1.

FIGURE 1

Derivation of iMSCs from iPSCs. (A) Schematic representation of the in situ genetic correction and targeted gene addition at the hrDNA locus in F8 Inv22 HA iPS cells. (B) Flow cytometry analysis of surface markers in iMSCs derived from iPSCs. HA-iMSCs were derived from F8 Inv22 HA iPS cells. 17-9-iMSCs were derived from F8-corrected iPS cells. T-7-iMSCs were derived from BDDF8-iPS cells. hiMSCs were derived from normal control hiPSCs. (C) Identification of osteogenic, chondrogenic, and adipogenic differential potential of iMSCs.